Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Assessment of Biochemical Profiles in Premenopausal and Postmenopausal Women with Breast Cancer

  • Yadav, Naval Kishor (Department of Biochemistry, College of Medical Sciences) ;
  • Poudel, Bibek (Department of Biochemistry, College of Medical Sciences) ;
  • Thanpari, C. (Department of Biochemistry, College of Medical Sciences) ;
  • Koner, Bidhan Chandra (Department of Biochemistry, College of Medical Sciences)
  • Published : 2012.07.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: The study was conducted to assess biochemical profiles in premenopausal and postmenopausal women having breast cancer. Materials and Methods: A hospital based case control study was carried out at Manipal Teaching Hospital (MTH), Pokhara, Nepal. The analysed variables were age, metabolic profile including total cholesterol, triglycerides, HDL-C, LDL-C, blood sugar, insulin concentration, C-peptide, HbA1c and selenium. Descriptive statistics and testing of hypothesis were used for the analysis using EPI INFO and SPSS 16 software. Results: In premenopausal women, significant differences were noted for total cholesterol (P value <0.001), triglycerides (P value 0.002), HbA1c level (P value <0.001), insulin concentration (P value 0.030), C-peptide concentration (P value 0.001), and selenium (P value <0.001) between cases and controls. Insignificant results were found for HDL-C (P value 0.749), LDL-C (P value 0.933), blood sugar (P value 0.59) and BMI (P value 0.746). Similarly, significant difference in total cholesterol (P value <0.001), triglycerides (P value 0.001), LDL-C (P value <0.001), HDL-C (P value 0.025), blood sugar (P value <0.001), insulin concentration (P value <0.001), c-peptide concentration (P value <0.001), HbA1c level (P value <0.001) and selenium (P value <0.001) were observed for postmenopausal patients and controls. Conclusions: Assessing metabolic changes and their management may be important for control of breast cancer and increased survival.

Keywords

References

  1. Abu-Bedair FA, El-Gamal BA, Ibrahim NA, et al (2003). Serum lipids and tissue DNA content in Egyptian female breast cancer patients. Jpn J Clin Oncol, 33, 278-82. https://doi.org/10.1093/jjco/hyg059
  2. Banu S, Adem V, Sakine C, et al (2003). Association between oxidative stress and selenium levels in patients with breast cancer at different clinical stages. J Trace Elements in Experimental Medicine, 16, 87-94. https://doi.org/10.1002/jtra.10030
  3. Benson JR, Jatoi I, Keisch M, et al (2009). Early breast cancer. Lancet, 373, 1463-79. https://doi.org/10.1016/S0140-6736(09)60316-0
  4. Brandt A, Bermejo JL, Sundquist J, et al (2010). Age of onset in familial breast cancer as background data for medical surveillance. Br J Cancer, 102, 42-7. https://doi.org/10.1038/sj.bjc.6605421
  5. Charalabopoulos K, Kotsalos A, Batistatou A, et al (2006). Selenium in serum and neoplastic tissue in breast cancer: correlation with CEA. Br J Can, 95, 674-6. https://doi.org/10.1038/sj.bjc.6603292
  6. Chow LW, Cheng CW, Wong JL, et al (2005). Serum lipid profiles in patients receiving endocrine treatment for breast cancer--the results from the Celecoxib Anti-Aromatase Neoadjuvant (CAAN) Trial. Biomed Pharmacother, 59, 302-5. https://doi.org/10.1016/j.biopha.2005.05.003
  7. Conlon MS, Johnson KC, Bewick MA, et al (2010). Smoking (active and passive), N-acetyltransferase 2, and risk of breast cancer. Cancer Epidemiol, 34, 142-9. https://doi.org/10.1016/j.canep.2010.02.001
  8. Cuzick J (2010). Breast cancer prevention in the developing World. Breast Cancer Res, 12, 9.
  9. Datta K, Choudhuri M, Guha S, et al (2012). Breast Cancer Scenario in a Regional Cancer Centre in Eastern India over Eight Years - Still a Major Public Health Problem. Asian Pac J Cancer Prev, 13, 809-13. https://doi.org/10.7314/APJCP.2012.13.3.809
  10. Frier BM, Ashby JP, Nairn IM, et al (1981). Plasma insulin, C-peptide and glucagon concentrations in patients with insulin-independent diabetes treated with chlorpropamide. Diab Metab, 7, 45-9.
  11. Furberg AS, Veierod MB, Wilsgaard T, et al (2004). Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst, 96, 1152-60. https://doi.org/10.1093/jnci/djh216
  12. Garland M, Morris JS, Stampfer MJ, et al (1995). Prospective study of toenail selenium levels and cancer among women. J Natl Cancer Inst, 87, 497-505. https://doi.org/10.1093/jnci/87.7.497
  13. Gooden PJ, Boyd NF, Hanna W, et al (1997). Elevated levels of plasma triglycerides are associated with histologically defined premenopausal breast cancer risk. Nutr Cancer, 27, 284-92. https://doi.org/10.1080/01635589709514539
  14. Hadjisawas A, Loizidou MA, Middleton N, et al (2010). An investigation of breast cancer risk factors in Cyprus: a case control study. BMC Cancer, 10, 447. https://doi.org/10.1186/1471-2407-10-447
  15. Hortobagyi GN, De La Garza Salazar J, Pritchard K, et al (2005). The global breast cancer burden: variations in epidemiology and survival. Clin Breast Cancer, 6, 391-401. https://doi.org/10.3816/CBC.2005.n.043
  16. Horwitz DL, Kuzuya L, Rubenstein AR (1976). Circulating serum C- peptide: A brief review of diagnostic implications. N Eng J Med, 295, 207-18. https://doi.org/10.1056/NEJM197607222950407
  17. Hoyer AP, Engholm G (1992). Serum lipids and breast cancer risk: a cohort study of 5, 207 Danish women. Cancer Causes Control, 3, 403-8. https://doi.org/10.1007/BF00051352
  18. Irwin ML, Duggan C, Wang CY, et al (2011). Fasting C-peptide levels and death resulting from all causes and breast cancer: the health, eating, activity, and lifestyle study. J Clin Oncol, 29, 47-53. https://doi.org/10.1200/JCO.2010.28.4752
  19. Jasim BT (2011). Determination the Erythrocyte glutathione peroxidase activity and Serum selenium level in patients with breast cancer. Tikrit J Pure Sci, 16, 4-8.
  20. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
  21. Kokoglu E, Karaarslan I, Karaarslan HM, et al (1994). Alterations of serum lipids and lipoproteins in breast cancer. Cancer Lett, 82, 175-8. https://doi.org/10.1016/0304-3835(94)90008-6
  22. Kuru B, Ozaslan C, Ozdemir P, et al (2002). Risk factors for breast cancer in Turkish women with early pregnancies and long-lasting lactation. Acta Oncol, 6, 556-61.
  23. Liao S, Li J, Wang L, et al (2010). Type 2 Diabetes Mellitus and Characteristics of Breast Cancer in China. Asian Pac J Cancer Prev, 11, 933-7.
  24. Lopez-Saez JB, Martinez-Rubio JA, Alvarez MM, et al (2008). Metabolic profile of breast cancer in a population of women in southern Spain. Open Clin Cancer J, 18, 1-6.
  25. Mahabir S, Baer DJ, Johnson LL, et al (2006). Usefulness of body mass index as a sufficient adiposity measurement for sex hormone concentration associations in postmenopausal women. Cancer Epidemiol Biomarkers Prev, 15, 2502-7. https://doi.org/10.1158/1055-9965.EPI-06-0499
  26. Mannisto S, Alfathan G, Virtanen M, et al (2000). Toenail selenium and breast cancer a case-control study in Finland. Eur J Clin Nutr, 54, 98-103. https://doi.org/10.1038/sj.ejcn.1600902
  27. McPherson K, Steel CM, Dixon JM (2000). Breast cancer-epidemiology, risk factors, and genetics. BMJ, 321, 624-8. https://doi.org/10.1136/bmj.321.7261.624
  28. Owiredu WK, Donkor S, Addai BM, et al (2009). Serum lipid profile of breast cancer patients. Pak J Biol Sci, 12, 332-8. https://doi.org/10.3923/pjbs.2009.332.338
  29. Qi XY, Zhang AY, Wu GL, et al (1994). The association between breast cancer and diet and other factors. Asia Pac J Public Health, 7, 98-104. https://doi.org/10.1177/101053959400700204
  30. Ray G, Husain SA (2001). Role of lipids, lipoproteins and vitamins in women with breast cancer. Clin Biochem, 34, 71-6. https://doi.org/10.1016/S0009-9120(00)00200-9
  31. Schootman M, Jeffe D, Lian M, et al (2009). The role of poverty rate and racial distribution in the geographic clustering of breast cancer survival among older women: a geographic and multilevel analysis. Am J Epidemiol, 169, 554-61.
  32. Sezer H, Yilmaz M, Gurler H, et al (2011). Breast cancer risk factors in Turkey: a hospital-based case-control study. Asian Pac J Cancer Prev, 12, 2317-22.
  33. Singh YP, Sayami P (2009). Management of breast cancer in Nepal. J Nepal Med Association, 48, 252-7.
  34. Takatani O, Okumoto T, Kosano H (1991). Genesis of breast cancer in Japanese: a possible relationship between sex hormone-binding globulin (SHBG) and serum lipid components. Breast Cancer Res Treat, 18, 527-9.
  35. Vona-Davis L, Rose DP (2009). The influence of socioeconomic disparities on breast cancer tumor biology and prognosis: a review. J Womens Health, 18, 883-93. https://doi.org/10.1089/jwh.2008.1127
  36. Zielinski CC, Stuller I, Rausch P, et al (1988). Increased serum concentrations of cholesterol and triglycerides in the progression of breast cancer. J Can Res Clin Oncol, 114, 514-8. https://doi.org/10.1007/BF00391503

Cited by

  1. The real role of prediagnostic high-density lipoprotein cholesterol and the cancer risk: a concise review vol.44, pp.1, 2013, https://doi.org/10.1111/eci.12185
  2. Does cancer risk increase with HbA1c, independent of diabetes? vol.110, pp.9, 2014, https://doi.org/10.1038/bjc.2014.150
  3. Plasma level of LDL-cholesterol at diagnosis is a predictor factor of breast tumor progression vol.14, pp.1, 2014, https://doi.org/10.1186/1471-2407-14-132
  4. Preparation of Selenium-enriched Bifidobacterium Longum and its Effect on Tumor Growth and Immune Function of Tumor-Bearing Mice vol.15, pp.8, 2014, https://doi.org/10.7314/APJCP.2014.15.8.3681
  5. Could Low Hdl-Cholesterol Levels Be an Unvalued Predictor of Cancer Risk?: A Retrospective Case Study vol.06, pp.12, 2015, https://doi.org/10.4236/ijcm.2015.612129
  6. Clinically Relevant Physical Benefits of Exercise Interventions in Breast Cancer Survivors vol.18, pp.2, 2016, https://doi.org/10.1007/s11912-015-0496-3
  7. Efficacy of Complementary Therapies in the Quality of Life of Breast Cancer Survivors vol.7, pp.2234-943X, 2018, https://doi.org/10.3389/fonc.2017.00326